Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0031099 (
periodontitis
)
12,489
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Probiotics have been demonstrated as a new paradigm to substitute antibiotic treatment for dental caries, gingivitis, and chronic
periodontitis
. The present work was conducted to compare the characteristics of oral care probiotics:
Weissella cibaria
CMU
(Chonnam Medical University) and four commercial probiotic strains. Survival rates under poor oral conditions, acid production, hydrogen peroxide production, as well as inhibition of biofilm formation, coaggregation, antibacterial activity, and inhibition of volatile sulfur compounds were evaluated. The viability of
W. cibaria
CMU
was not affected by treatment of 100 mg/L lysozyme for 90 min and 1 mM hydrogen peroxide for 6 h. Interestingly,
W. cibaria
produced less acid and more hydrogen peroxide than the other four probiotics.
W. cibaria
inhibited biofilm formation by
Streptococcus mutans
at lower concentrations (
S. mutans
/
CMU
= 8) and efficiently coaggregated with
Fusobacterium nucleatum
.
W. cibaria
CMU
and two commercial probiotics, including
Lactobacillus salivarius
and
Lactobacillus reuteri
, showed high antibacterial activities (>97%) against cariogens (
S. mutans
and
Streptococcus sobrinus
), and against periodontopathogens (
F. nucleatum
and
Porphyromonas gingivalis
). All of the lactic acid bacterial strains in this study significantly reduced levels of hydrogen sulfide and methyl mercaptan produced by
F. nucleatum
and
P. gingivalis
(
p
< 0.05). These results suggest that
W. cibaria
CMU
is applicable as an oral care probiotic.
...
PMID:Comparative Study on the Characteristics of Weissella cibaria CMU and Probiotic Strains for Oral Care. 2799